Greenbrook provides Transcranial Magnetic Stimulation (TMS) therapy,

an FDA-cleared, non-invasive therapy for the treatment of Major Depressive Disorder and other mental health disorders in the United States.

TMS therapy provides local electromagnetic stimulation to specific brain regions known to be directly associated with mood regulation.

Recent News

Get the atai
Investor’s Kit now.

Compounds

Market Cap

TSX: GTMS